Patients Treated for SCID (1968-Present)

计划入组 1,007 人 · 首次发布于 2011 年 5 月 2 日

Natural History Study of SCID Disorders

计划入组 690 人 · 首次发布于 2010 年 8 月 23 日

Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene Therapy

计划入组 18 人 · 首次发布于 2025 年 2 月 28 日

Escin

C₁₁₀H₁₇₂O₄₈

SCMod-1

beta-Escin

C₅₅H₈₆O₂₄

Euclid Vision Corporation

United States

Theriva Biologics Presents Phase 1b/2a Safety Data for SYN-004 in Hematopoietic Cell Transplant Recipients at ESCMID Global

BioVersys Reports Strong Survival Benefit in Phase 2 Trial of BV100 for Carbapenem-Resistant Acinetobacter Infections

Longhorn Vaccines Advances Universal Flu Vaccine with Broad Cross-Species Protection